Brand Intelligence Graphproduct
Company Overview
About Tylenol
Tylenol is a global over-the-counter acetaminophen (paracetamol) pain relief and fever reducer brand — owned by Kenvue (NYSE: KVUE), the consumer health company spun off from Johnson & Johnson in May 2023 at a $41 billion IPO valuation, and subject to a pending $48.7 billion acquisition by Kimberly-Clark announced in November 2025 (expected to close second half 2026) — providing consumers with the world's most widely used analgesic through product lines including Tylenol Extra Strength, Tylenol PM, Tylenol Rapid Release Gels, Tylenol Children's, and Tylenol Arthritis Pain for adults and pediatric pain and fever management. Generating approximately $2 billion in annual retail sales as one of Kenvue's flagship brands alongside Neutrogena, Band-Aid, Listerine, and Zyrtec, Tylenol is the #1 recommended pain reliever by doctors and pharmacists in the United States. Originally marketed by McNeil Laboratories (acquired by J&J in 1959), the brand was approved for OTC sale in 1960.
Business Model & Competitive Advantage
Tylenol's acetaminophen formulation addresses the most common everyday pain and fever management needs across the broadest patient population — including groups who cannot safely take NSAIDs (ibuprofen, naproxen, aspirin): patients with ulcers, gastrointestinal conditions, or kidney disease who cannot tolerate NSAID gastric irritation; patients on blood thinners (anticoagulants) where NSAIDs increase bleeding risk; pregnant women for whom acetaminophen is considered the safest OTC analgesic; and elderly patients where NSAID cardiovascular and renal risks are higher. Tylenol's combination formulations (Tylenol PM with diphenhydramine for nighttime, Tylenol Cold + Flu for multi-symptom relief) extend the brand into adjacent OTC categories — making Tylenol the first-reach OTC choice for households managing pain, fever, cold, and sleep.
Competitive Landscape 2025–2026
In 2025, Tylenol (Kenvue) competes in the OTC analgesic, pain relief, and fever reducer market with Advil (Haleon, ibuprofen, $500M+ US revenue), Aleve (Bayer, naproxen), and store brand acetaminophen (private label, 50%+ acetaminophen unit share) for pharmacist recommendation, retail shelf positioning, and consumer household analgesic purchasing. Kimberly-Clark's pending $48.7 billion acquisition of Kenvue (announced November 2025) will bring Tylenol under the same portfolio as Kleenex, Huggies, Kotex, and Scott — creating a diversified consumer products company competing with Procter & Gamble and Unilever across health, hygiene, and household categories. The 2025 strategy under Kenvue (pre-Kimberly-Clark close) focuses on premium product innovation (Tylenol Precise extended-release), growing the e-commerce direct channel, and defending acetaminophen category leadership against store brand share gains.
The Tylenol Story
Founders
Recent Activity
View all →Company Timeline
Major milestones in Tylenol's journey
Leadership Team
Meet the leaders behind Tylenol
Thibaut Mongon
Thibaut Mongon serves as CEO of Kenvue, the parent company of Tylenol. He leads the consumer health company spun off from Johnson & Johnson in 2023.
Key Differentiators
Market Leader
Tylenol is recognized as a market leader in the Healthcare sector, demonstrating strong industry presence and customer trust.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Browser Use
Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
PointClickCare
PointClickCare is North America's leading cloud-based software platform for the long-term and post-acute care (LTPAC) market, headquartered in Mississauga, Ontario, Canada. Founded in 1999, the compan
CoverMyMeds
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline t
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
Compare Tylenol with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Tylenol? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Tylenol Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Tylenol vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →